Effect of Asymptomatic and Symptomatic COVID-19 on Acute Ischemic Stroke Revascularization Outcomes.

"Disclosures Dr Nguyen is on the Advisory Board of Idorsia. Dr Michel received research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, and the University of Lausanne. The other authors report no conflicts. Global COVID-19 Stroke Registry: R. Herzig received research grants from the Ministry of Health of the Czech Republic (Grant number DRO – UHHK 00179906) and Charles University, Czech Republic (Cooperatio Program). C. Nolte received research grants from the German Ministry of Research and Education, the German Center for Neurodegenerative Diseases, and the German Center for Cardiovascular Research and is a speaker and advisory for Abbott, Alexion, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, and Pfizer Pharma. S. Tjoumakaris is on Advisory Medtronic and MicroVention. J. Min is on Advisory Medtronic and Abbott. M.-A. Khan received research grants from National Institutes of Health, Spectrum Health-Michigan State University Research Alliance, and Genentech. A. Zini received consultation and travel expenses from Alexion-AstraZeneca, CSL Behring, and Boehringer Ingelheim and is on the steering committee of the OCEANIC-STROKE trial (A Study to Test Asundexian to Prevent a Clot-Related Stroke in Participants After an Acute Ischemic Stroke or High-Risk TIA/Mini-Stroke). A. Slowik and P. Wrona received research grant from European Research Area Network (ERA-NET) - Network of European Funding for Neuroscience Research (NEURON)/21/2020 Identification and clinical validation of biomarkers for long-term outcome after cerebral ischaemia (iBioStroke)."

"Sources of Funding The Czech stroke registry was supported by STROCZECH (Czech Stroke Research Network) within CZEch Clinical Research Infrastructure Network (CZECRIN) (No. LM2023049) funded by Czech Republic."

"Data from each participating center were anonymized and sent to the coordinating center (Lausanne University Hospital). According to the local ethics committee regulations and national laws, each center was responsible for obtaining ethical approval for data collection and international data sharing. Informed consent was waived due to the retrospective nature of this study with anonymized data. This study was conducted according to the principles of the Declaration of Helsinki. In the coordinating center in Lausanne, approval of the institutional review board and patient consent was not required according to the Swiss Federal Act on Research Involving Human Beings (2011, Human Research Act, Article 3) as all data were anonymized and the project involved assessing safety and quality of routine AIS management in participating centers. The study was registered under https://www.clinicaltrials.gov (NCT04895462). REGISTRATION:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04895462."